Cargando…
Herpesvirus reactivation during severe COVID-19 and high rate of immune defect
OBJECTIVE: We assessed herpesvirus reactivation in severe SARS-CoV-2 infection. METHODS: Retrospective study including consecutive patients admitted to an onco-hematology intensive care unit (ICU) for severe COVID-19. Replication of EBV, CMV, and HSV was evaluated. Competing risk analyses were used...
Autores principales: | Saade, A., Moratelli, G., Azoulay, E., Darmon, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317452/ https://www.ncbi.nlm.nih.gov/pubmed/34332165 http://dx.doi.org/10.1016/j.idnow.2021.07.005 |
Ejemplares similares
-
Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect
por: Saade, Anastasia, et al.
Publicado: (2021) -
The human herpesvirus-type 8 is not involved in malignant melanoma
por: Deichmann, M, et al.
Publicado: (1999) -
In vitro inhibition of Cyprinid herpesvirus-3 replication by RNAi
por: Gotesman, Michael, et al.
Publicado: (2014) -
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma
por: Jauhiainen, Maria K., et al.
Publicado: (2023) -
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)